fda drug shortages semaglutide injection resolved date 2025 Announces End to Shortage, Impacting Compounders and Telehealth Providers Offering Injectable GLP-1 Drugs GLP-1 Pipeline Update: November 2025

Gastrointestinal Effects and Nutrient Malabsorption Common side effects such as nausea, early satiety, and constipation may further restrict dietary intake and impair nutrient absorption - particularly of fat-soluble vitamins and dietary protein

ID Weight approach has been life-changing for us, says Cecil

10.4103/NRR.NRR-D-24-00001 60 SteinJ

The SELECT cardiovascular outcomes trial further demonstrated that semaglutide-induced weight loss translates to meaningful clinical benefits, including a 20% reduction in major adverse cardiovascular events in patients with established cardiovascular disease

Front Immunol (2012) 3:165

Each additional receptor target adds complexity to the side effect profile, the dose-response relationship, and the long-term safety considerations